Adult glioblastoma multiforme survival in the temozolomide era: A population‐based analysis of Surveillance, Epidemiology, and End Results registries
Darefsky AS, King JT, Dubrow R. Adult glioblastoma multiforme survival in the temozolomide era: A population‐based analysis of Surveillance, Epidemiology, and End Results registries. Cancer 2011, 118: 2163-2172. PMID: 21882183, PMCID: PMC3235223, DOI: 10.1002/cncr.26494.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAntineoplastic Agents, AlkylatingBrain NeoplasmsDacarbazineFemaleGlioblastomaHumansMaleMiddle AgedPrognosisSEER ProgramTemozolomideTreatment OutcomeUnited StatesConceptsHazard ratioTemozolomide eraMultivariate-adjusted hazard ratiosEnd Results Program databaseKaplan-Meier methodPopulation-based surveillanceTwo-year survivalAge-stratified analysisConfidence intervalsPopulation-based analysisAge 20 yearsProportional hazards modelProgressive decreaseTemozolomide useOlder patientsSurgical resectionSurvival improvementTreatment advancesProgram databaseGBM patientsHazards modelGBM treatmentAge 20Age groupsGlioblastoma multiforme survival